Global Pancreatic Cancer Therapeutics Market 2019-2023| Expanding ResearchPosted by sarahbennu on January 22nd, 2020 The global pancreatic cancer therapeutics market research report forecasts the market to grow at a CAGR of over 8% during the forecast period. The expanding research in immunotherapy will be one of the significant trends in the global pancreatic cancer therapeutics market during 2019-2023. To find the best available therapy that minimizes the chances of cancer relapse, significant research is being undertaken in the global pancreatic cancer therapeutics market. The immunotherapy products such as immune checkpoint inhibitors and vaccines are a part of active research.
Looking for more information on this market? Request a free sample report Global pancreatic cancer therapeutics market: Rising prevalence of pancreatic cancer The pancreatic cancer is the most common type of gastrointestinal cancer, whose incidence is increasing in developed countries. The high incidence of pancreatic cancer in developed countries is due to the high diagnosis rates and increasing awareness. According to a research analyst at Technavio, “There are several factors such as tobacco smoking, age, obesity, diabetes, pancreatitis, alcohol consumption, and family history of pancreatic cancer, which contribute to an increase in the risk of pancreatic cancer. Tobacco smoking is a prime risk factor among these factors, as it majorly accounts for the rising incidence of pancreatic cancer globally.” Global pancreatic cancer therapeutics market: Segmentation analysis This global pancreatic cancer therapeutics market analysis report provides market segmentation by product (targeted therapy and chemotherapy), by type (exocrine pancreatic cancer and endocrine pancreatic cancer), and by region (the Americas, APAC, and EMEA). This report provides an in-depth analysis of the prominent factors influencing the market, including drivers, opportunities, trends, and industry-specific challenges. Of the two major products, the targeted therapy segment held the largest pancreatic cancer therapeutics market share in 2018, contributing to nearly 51% of the market. This product segment will dominate the global market throughout the forecast period. The Americas held the largest share of the market in 2018, accounting for close to 53% share. It was followed by EMEA and APAC respectively. The Americas is expected to dominate the market throughout the period 2019-2023. This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more. Some of the key topics covered in the report include: Market Landscape
Market Sizing
Five Forces Analysis Market Segmentation Geographical Segmentation
Market Drivers Market Challenges Market Trends Vendor Landscape
Like it? Share it! More by this author |
